As LRP-TSW contains live bacteria that impact the skin’s microbiota, the water itself is considered to be a probiotic. 2 In discussing the safety of drinking water, the World Health Organization (WHO-2006) recommends that “Water entering the distribution system must be microbiologically safe”, meaning that it should not be contaminated by pathogenic microorganisms. However, the WHO does not contend that drinking water is microorganism free, and in fact, bacteria are present in relatively high numbers (102 to 104 cells/ml) in drinking water. 4-6 Probiotic versus Prebiotic Water While a probiotic is a product containing live microorganisms, a product containing an ingredient or nutrient that selectively stimulates or inhibits the growth or activity of commensal skin bacteria, is considered a prebiotic. 7 Filtered LRP-TSW, that does not contain living bacteria can be considered a prebiotic. The product has a low mineral content (<1 g/L) and specific trace elements like Se and Sr, which are necessary for cellular functions including enzyme activity. Intrinsically its major biological properties are free radical “scavengers”, anti-inflammatory and toxic heavy metals protection. Prebiotic TSW has been shown to be beneficial in subjects with dry but otherwise healthy skin. 7 The effect of LRP-TSW using a commercial spray (2 sprays per application) twice a day for 14 days on inner forearms, was evaluated in 70 healthy subjects with dry skin (corneometry measurement ≤ 50 au). 7 Thirty minutes after the last application of LRP-TSW microbiome sampling of the treated and nearby untreated skin was performed to determine bacterial community composition. Treatment resulted in a significant increase in Gram-negative bacteria and a decrease of Gram-positive bacteria on the skin surface of treated skin areas versus nearby untreated areas was noted (Figure 2). Interestingly, topical application of a moisturizer containing LRP-TSW in a similar protocol demonstrated a significantly increased level of Xanthomonas genus correlated with increased skin hydration levels (Figure 3). Effect of Balneotherapy on the Skin Microbiome in Some Inflammatory Skin Diseases The microbiota is the collection of microorganisms that live on and in our bodies. The complex diversity and composition of microbial communities on the skin vary by skin region5 and between individuals. 5,6 The skin microbiota is composed of around 80% Gram-positive and 20% Gram-negative bacteria. Firmicutes and Actinobacteria for Gram-positive bacteria, while Proteobacteria and Bacteroidetes are the main phyla of skin Gram-negative bacteria. The bacterial diversity is mainly driven by Gram-negative bacteria, and abundance by Gram-positive2
bacteria. Several diseases such as atopic dermatitis and psoriasis have been found to be associated with changes in the composition of the skin microbiota. 8-11 Balneotherapy using probiotic LRP-TSW water has been shown to improve the skin microbiota in a variety of inflammatory skin conditions. Effect of LRP-TSW on Atopic Dermatitis The effect of LRP-TSW balneotherapy on the microbiome has been evaluated in patients with atopic dermatitis. Microbial samples were taken from 31 patients with atopic dermatitis on both affected and adjacent unaffected skin. Repeat samples were taken after 21 days of balneotherapy to analyze microbiota diversity (Shannon index), bacterial phyla, and genus abundance. At baseline, Shannon diversity was lower in the lesional AD skin as compared to adjacent clinically normal skin. After balneotherapy, Shannon diversity index increased in the lesional areas and became similar to what was observed in the clinically normal appearing skin. In addition, balneotherapy resulted in a reduction of Firmicutes organisms mainly Staphylococci, along with an increase in other bacterial phyla. Additionally, an increase in the amount of Xanthomonas genus was also observed (Figure 4). The increase in bacterial diversity after balneotherapy was correlated with a significant increase in Gram-negative bacteria and a significant decrease of Gram-positive bacteria on the skin (Figure 5).In a 2014 study, 100 patients suffering from chronic AD were treated with LRP-TSW balneotherapy at the LRP Treatment Center. 12 After treatment, SCORing Atopic Dermatitis (SCORAD) scores significantly (P less than 0.0001) improved in 90% of subjects, with a mean decrease of 38% from 46.8 (SD±1.9) to 27.8 (SD±1.5). Mean EASI (Eczema Area and Severity Index) scores also significantly (P less than 0.0001) improved in 82% of patients from 9.3 (SD±0.8) to 4.6 (SD±0.6). Clinical efficacy correlated with significant improvements in quality of life measures, as Dermatology Life Quality Index (DLQI) and Children’s DLQI (CDLQI) (both P less than 0.0001). There was a mean reduction in DLQI scores of 8.1 (SD±1.0) to 4.1 (SD±0.7) and a 28% reduction in CDLQI scores of 7.5 (SD±0.7) to 4.5 (SD±0.5). Balneotherapy was reported to provide long-lasting results, with clinical and quality of life improvements maintained for an average of 6 months. 12 LRP-TSW based skincare products have also been shown to improve the diversity of the skin microbiome in eczema patients, after three months of applying an emollient containing at least a 50% concentration of LRP-TSW 12 and a supplement with a8-11
biomass of non-pathogenic Gram-negative bacteria such as Vitreoscilla filiformis (LRP-VFB). 13 Improvements were observed inthe microbiome of the skin of AD patients with an increase in microbial diversity. Psoriasis Vulgaris The skin microbiome has been evaluated in patients with moderate to severe psoriasis vulgaris at the LRP thermal care center. Similar to studies performed in AD, bacterial swabs were taken from affected and nearby unaffected skin before and after three weeks of TSW balneotherapy. 14 While balneotherapy resulted in significant improvements in clinical signs, as measured by Psoriasis Area and Severity Index (PASI) scores, no significant change in the Shannon diversity index was observed. The average taxonomic composition of skin bacterial communities associated with the unaffected and affected skin of psoriatic patients post-balneotherapy showed a significant increase in the level of Xanthomonas genus and, to a lesser extent, Corynebacterium genus. 14 The Xanthomonas genus belongs to the main Xanthomonadaceae family found in LRPTSW and also, at a low concentration, on the naturally healthy skin. 14 This is associated with a decrease in Staphylococcus genus. Additionally, in this patient group after balneotherapy, there was a significant increase of skin surface Gram-negative bacteria and a significant decrease of Gram-positive bacteria observed (Figure 6). Two studies have been performed specifically to evaluate the therapeutic benefits of balneotherapy in treating psoriasis. In 1995, 92 patients with moderate plaque psoriasis were treated with balneotherapy. After treatment, there was a mean reduction in PASI scores of 47% (from 5.5±0.5 to 2.9±0.3, P less than 0.001), 8% of patients were completely clear and 48% improved by more than 50%. While the clinical significance is unknown, an increase in the mean Se plasma level (from 77.1±2.1 to 90.4±2.7 μg/L, P less than equal to 0.01) was noted after treatment and correlated with the reduction of PASI (rs=0.31, P less than 0.01).3 In 2012, 199 patients with severe plaque psoriasis (74.4%) or guttate psoriasis (12.1%) were treated with balneotherapy. Aftertreatment, mean PASI scores were reduced by 57% (from 17.6±0.9 to 7.8±0.5, P less than equal to 0.0001), 96% of patients showed some degree of improvement in PASI scores, 26% achieved a PASI 75, and 64% of patients achieved a PASI 50 response, 78% of patients experienced improvement in DLQI (from 5.9±0.2 to 3.4±0.15, P less than equal to 0.0001). Among these patients, 75% had previously received balneotherapy with an average of 8±9 treatments (max=57 - min=1). Patients reported that balneotherapy continued to improve their quality of life for 7±3 months and gave a sustained remission of psoriasis for an average of 6±3 months following treatment.Vitreoscilla filiformis
Healthy human skin normally consists of a mix of Gram-positive and Gram-negative bacteria of at least 19 phyla. Actinobacteria, Firmicutes, Proteobacteria, and Bacteroides are the predominant bacterial phyla in the human skin, regardless of body site. 9,10 Within these phyla, the 3 most abundant genera are: Propionibacterium, Corynebacterium, and Staphylococcus. 9,10 A variety of inflammatory skin diseases are associated with abnormalities in the microbiota with a loss of diversity. 7 There is anoverrepresentation of Firmicute organisms, like Staphylococcisp. and an underrepresentation of Actinobacteria, Proteobacteria, and Cyanobacteria. 12 Treatment of AD with LRP-TSW has been associated with improvements in diversity of the microbiota in patients with AD as well as clinically meaningful improvements in signs of the disease itself. 12-149,10
LRP-TSW may be considered a probiotic, as it naturally contains a low concentration of bacteria, with a high microbial diversity and more Gram-negative than Gram-positive bacteria. Clinical studies indicate that balneotherapy with probiotic LRP-TSW stimulates the growth of Gram-negative bacteria, particularly on Xanthomonadaceae, at the expense of Gram-positive bacteria at the skin surface improving microbial diversity associated with decreased severity of inflammatory skin conditions. 12-14 Without the use of an antibiotic, LRP-TSW can modify the microbiota on human skin. Decreases in Staphylococci sp. have been observed along with increases in Gram-negative Xanthomonadaceae levels, even after topical application of LRP-TSW. 12-14 Moreover, these improvements in microbiota have been correlated to clinical improvement of the skin in conditions like AD. Although the therapeutic mechanisms of balneotherapy are not completely understood, in addition to a probiotic effect LRP-TSW may have anti-inflammatory effects as well. Finally, it exhibits a prebiotic effect on Gram-negative bacteria and on the Xanthomonadaceae family, as patients treated with prebiotic demonstrate improvements in dryness and skin barrier function.712-14
Skin microbiome studies are challenging and costly. Currently results are a discussion of in-vivo data that demonstrated microbiome alterations correlated with skin condition improvement when using balneotherapy at the source with probiotic LRP-TSW, topical filtered LRP-TSW, and skincare containing more than 50% LRP-TSW. More comparative studies using TSW with different mineral compositions are needed to better understand the mechanism(s) of action.
LRP-TSW exhibits both prebiotic for its mineral composition and probiotic properties for its bacterial diversity. LRP balneotherapy has been shown to effectively treat inflammatory skin conditions including AD and psoriasis. An abnormal microbiota is associated with skin disease and improvements in microbial diversity correlated with clinical improvements in the severity of the skin disease itself. LRP-TSW has been shown in clinical studies to improve skin microbiome diversity as well as the decreased severity of active lesions in skin diseases like AD, psoriasis, and general dryness in otherwise healthy skin. The concentration of minerals and non-pathogenic microbes likely explain its therapeutic benefit and make it an attractive option for treating inflammatory skin diseases.
Joshua Zeichner has served as an advisory board member and consultant to La Roche Posay. Sophie Seité is an employee of La Roche-Posay, France.
The author would like to thank Dr. Andriessen of RBC Consultants for writing assistance. Her support was funded by La Roche-Posay Dermatological Laboratories, France.
- Gambichler T, Kuster W, Kreuter A et al. Balneotherapy combined treatment of psoriasis vulgaris and atopic dermatitis with salt water baths and artificial ultraviolet radiation. J Eur Acad Dermatol Venereol. 2000;14:425-428.
- Seité S. Thermal waters as cosmeceuticals: La Roche-Posay thermal spring water example. Clin Cosmet Investig Dermatol. 2013;6:23-28.
- Pinton J, Friden H, Kettaneh-Wold N, et al. Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris. Br J Dermatol. 1995;133:344-347.
- Vital M, Dignum M, Magic-Knezev A, et al. Flow cytometry and adenosine tri-phosphate analysis: alternative possibilities to evaluate major bacteriological changes in drinking water treatment and distribution systems. Water Res. 2012;46:4665-4676.
- Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694-1697.
- Fierer N, Lauber CL, Zhou N, et al. Forensic identification using skin bacterial communities. Proc Natl Acad Sci U S A. 2010;107:6477-6481.
- Baldwin HE, Bhatia ND, Friedman A, Eng RM, Seité S. The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin Barrier. J Drugs Dermatol. 2017;1;16(1):12-18.
- Schommer NN, Gallo RL. Structure and function of the human skin microbiome. Trends Microbiol. 2013;21:660-668.
- Grice EA, Segre JA. The human microbiome: our second genome. Annu Rev Genomics Hum Genet. 2012;13:151-170.
- Grice EA. The intersection of microbiome and host at the skin interface: genomic-and metagenomic-based insights. Genome Res. 2015;25:1514-1520.
- Rosenthal M, Goldberg D, Aiello A, et al. Skin microbiota: microbial community structure and its potential association with health and disease. Infect Genet Evol. 2011;11:839-848.
- Seité S, Flores GE, Henley JB, et al. Microbiome of the affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol. 2014;13:1365-1372.
- Seité S, Zelenkova H, Martin R. Clinical efficacy of emollients in atopic dermatitis patients - relationship with the skin microbiota modification. Clin Cosmet Investig Dermatol. 2017;10:25-33.
- Martin R, Henley JB, Sarrazin P, et al. Skin Microbiome in Patients With Psoriasis Before and After Balneotherapy at the Thermal Care Center of La Roche-Posay. J Drugs Dermatol. 2015;14:1400-1405.